Marketwire - Chemicals

Senscient, Inc. Receives the ISA InTech Gold Innovator's Award for ELDS Gas Detector

Fri, 06 Nov 2009 11:33:00 EST

LEAGUE CITY, TX--(Marketwire - November 6, 2009) - The International Society of Automation (ISA) named Senscient, Inc. as the winner of its Gold InTech Innovator's Award. The award was presented at ISA EXPO 2009 in Houston.

The InTech Innovator's Awards recognize companies that have made significant and unique contributions to any field in the automation profession. These contributions include, but are not limited to, design, development, equipment, instrumentation, or an innovative service or contribution in automation.

Canexus Announces November Distribution

Fri, 06 Nov 2009 10:21:00 EST

CALGARY, ALBERTA--(Marketwire - Nov. 6, 2009) -�Canexus Income Fund (TSX:CUS.UN) (the "Fund") today announced the cash distribution for the period November 1, 2009, to November 30, 2009, has been set at $0.0456 per unit. The distribution will be paid on December 15, 2009, to unitholders of record as at November 30, 2009. This payment is consistent with the Fund's distribution policy.

The Fund has a Distribution Reinvestment Plan ("DRIP") that enables participants to automatically reinvest monthly distributions in additional trust units of the Fund. More information on the DRIP is available on the Canexus website at www.canexus.ca.�

CTI Industries Corporation Announces Presentation at the Wall Street Analyst Forum in New York City

Thu, 05 Nov 2009 12:00:00 EST

BARRINGTON, IL--(Marketwire - November 5, 2009) - CTI Industries Corporation (NASDAQ: CTIB), a manufacturer and marketer of metallized balloons, latex balloons, novelty items, packaging and storage bags and pouches and printed and laminated films, today announced that Stephen M. Merrick, the Company's Executive Vice President, will present the Company's general business outlook with investors and financial analysts on Thursday, November 19, 2009, at the Wall Street Analyst Forum in New York City.

Itronics 2009 Nine Month Revenues Increase 10 Percent to $2.6 Million; Silver Sales up 101 Percent

Thu, 05 Nov 2009 09:15:00 EST

Strong Growth Being Driven by Environmentally Green Clean Technology

Koppers Holdings Inc. Reports Third Quarter 2009 Results

Thu, 05 Nov 2009 08:36:00 EST

Third Quarter 2009 Sales of $290 Million on Par With Second Quarter Sales; Third Quarter Sales for Carbon Materials & Chemicals Increased 8% From Second Quarter; Third Quarter EPS Increases 40% to $0.80 Over Second Quarter After Benefit of Reduced Tax Rate; Cash on Hand Increases to $131 Million

Agrium Makes Best and Final Offer for CF Industries of $45.00 Per Share in Cash Plus One Agrium Share

Thu, 05 Nov 2009 07:15:00 EST

Urges CF stockholders to send clear message to CF board to accept Agrium's compelling final offer Receives "No-Action" letter from Canadian Competition Bureau and Re-files notification under Hart-Scott-Rodino

Invitation to press- and analyst conference

Thu, 05 Nov 2009 04:27:00 EST

STOCKHOLM, SWEDEN--(Marketwire - November 5, 2009) -

Biovitrum AB (publ) will hold a press conference today to present the proposed combination with Swedish Orphan International AB.

Time:               11:00 (CET), today Thursday November 5, 2009
Venue:             Carnegie's offices, Regeringsgatan 56 in
Stockholm, Sweden

To follow the press conference over telephone, please use the following dial-in number: + 46 (0) 850 520 270.

Conference call at 16:00 (CET)

The creation of a new niche specialty pharmaceutical company focused on rare diseases - with strong cash flow generation and growth potential

Thu, 05 Nov 2009 03:51:00 EST

STOCKHOLM, SWEDEN--(Marketwire - November 5, 2009) -

Biovitrum and Swedish Orphan will be combined forming Swedish Orphan Biovitrum with pro forma revenues 2009 of approximately SEK 2 billion and an EBITDA margin of 15 percent. Biovitrum will pay an upfront consideration of SEK 3.5 billion (on a cash and debt free basis), to be financed by a fully guaranteed rights issue, an issue in kind and bank financing. The Transaction will be instantly accretive to earnings per share for Biovitrum's shareholders.

NeuroVive: NeuroVive doses last patient in clinical trial of cremophor(R)- free cyclosporine i.v. NeuroSTAT(R)

Thu, 05 Nov 2009 03:06:00 EST

LUND, SWEDEN--(Marketwire - November 5, 2009) -

NeuroVive Pharmaceutical AB, of Lund, Sweden, announced that on November 3, 2009 it completed the clinical phase of its study investigating tolerability and pharmacokinetics of the cremophor�-free cyclosporine i.v. formula NeuroSTAT�.

CEO Eskil Elm�r comments that "This study in 52 healthy subjects is a direct comparison of NeuroVive's injectable cyclosporine product NeuroSTAT� with Novartis's product Sandimmune� Injection. This is an important milestone in the development of NeuroVive's first pharmaceutical product for clinical use in patients with acute brain damage. Further, if the final analysis of the study is successful it will open the opportunity to develop or outlicense the product NeuroSTAT� for existing indications for intravenous cyclosporine A (such as immunosuppression). We expect to make NeuroSTAT� available for clinical trials and sales on a named-patient basis."

Active Biotech's election committee appointed

Thu, 05 Nov 2009 02:41:00 EST

LUND, SWEDEN--(Marketwire - November 5, 2009) - In accordance with a decision made by the Annual General Meeting held on May 7, 2009, the Election Committee shall comprise the representatives for the three largest shareholders on September 30 and the Board Chairman.

For the 2010 Annual General Meeting, the Election Committee shall propose Board members and a Board Chairman, and fees to Board members and auditors. The following individuals were appointed representatives for the largest shareholders and, accordingly, are members of the Election Committee:

Active Biotech AB Interim Report, January - September 2009

Thu, 05 Nov 2009 02:38:00 EST

LUND, SWEDEN--(Marketwire - November 5, 2009) -

* Laquinimod -- new data presented at ECTRIMS
* 57-57 -- exploratory clinical trial in progress
* RhuDexT -- clinical development to continue following feedback
  from UK MHRA
* ANYARA -- complete Phase I data published
* TASQ -- complete Phase I data published
* ISI -- project proceeding according to plan
* Net sales of SEK 7.7 M (8.8)
* Operating loss of SEK 164.6 M (loss: 167.0)
* Loss after tax of SEK 165.1 M (loss: 162.0)
* Loss per share for the period amounted to SEK 2.90 (loss: 3.30)
* Number of shares at the end of the period, thousands (incl.
  warrants): 64,943



  For further information, please contact:
  Tomas Leanderson
  President and CEO
  Tel: +46 (0)46-19 20 95

  G�ran Forsberg
  VP Investor Relations & Business Development
  Tel: +46 (0)46-19 11 54

  Hans Kolam
  CFO
  Tel: +46 (0)46-19 20 44

  Active Biotech AB
  (Corp. Reg. No. 556223-9227)
  PO Box 724, SE-220 07 Lund
  Sweden

Willbros Awarded Two Spreads of Fayetteville Express Pipeline Construction

Wed, 04 Nov 2009 18:01:00 EST

HOUSTON, TX--(Marketwire - November 4, 2009) - Willbros Group, Inc. (NYSE: WG) announced today that it has been awarded the construction contract for spreads three and four of the Fayetteville Express Pipeline (FEP). The approximately 185-mile natural gas pipeline will originate in Conway County, Arkansas, continue eastward through White County, Arkansas, and terminate at an interconnect with Trunkline Gas Company in Panola County, Mississippi. FEP will parallel existing utility corridors where possible to minimize impact to the environment, communities and landowners. FEP is a joint venture between Energy Transfer Partners, L.P. and Kinder Morgan Energy Partners, L.P. The Willbros scope of work includes 120 miles of 42-inch pipeline, beginning near Bald Knob, Arkansas and ending at the Trunkline interconnection. The project is expected to begin construction in April 2010 and be completed in October 2010.

NiSource Gas Transmission & Storage and Willbros Complete Long-Term Alliance Agreement

Wed, 04 Nov 2009 18:00:00 EST

HOUSTON, TX--(Marketwire - November 4, 2009) - NiSource Gas Transmission & Storage (NGT&S), a unit of NiSource Inc. (NYSE: NI), and Willbros Group, Inc. (NYSE: WG) announced today that they have executed a long-term alliance agreement whereby Willbros will be the provider of program development, project management, design, engineering, geographic information systems (GIS), Integrity and maintenance services with respect to pipeline system projects for NGT&S.

RAE Systems Reports Third Quarter 2009 Results

Wed, 04 Nov 2009 16:10:00 EST

Achieves Non-GAAP Profitability; Books an Accrual for Potential FCPA Settlement With DOJ & SEC

Clorox Announces Pricing of $300 Million Senior Notes

Wed, 04 Nov 2009 15:24:00 EST

OAKLAND, CA--(Marketwire - November 4, 2009) - The Clorox Company (NYSE: CLX) today announced that it has priced an offering of $300 million aggregate principal amount of its 3.55 percent senior notes due Nov. 1, 2015, in an underwritten registered public offering. The offering was made pursuant to an effective shelf registration statement Clorox filed with the Securities and Exchange Commission (SEC) on Oct. 3, 2007, as amended on Nov. 4, 2009. The offering is expected to close on Nov. 9, 2009, subject to customary closing conditions. Clorox intends to use the net proceeds from the offering to retire commercial paper.

Koppers Holdings Inc. Board Declares Regular Dividend

Wed, 04 Nov 2009 10:59:00 EST

PITTSBURGH, PA--(Marketwire - November 4, 2009) - The Board of Directors of Koppers Holdings Inc. (NYSE: KOP) today declared a quarterly dividend of $0.22 per common share, payable January 8, 2010, to stockholders of record as of the close of business on November 16, 2009.

About Koppers

Koppers, with corporate headquarters and a research center in Pittsburgh, Pennsylvania, is a global integrated producer of carbon compounds and treated wood products. Including its joint ventures, Koppers operates facilities in the United States, United Kingdom, Denmark, Australia and China. The stock of Koppers Holdings Inc. is publicly traded on the New York Stock Exchange under the symbol "KOP." For more information, visit us on the Web: www.koppers.com. Questions concerning investor relations should be directed to Brian H. McCurrie at 412 227 2153 or Michael W. Snyder at 412 227 2131.

BMTS Announces the Introduction of the Demolizer II System Into the Geisinger Health System

Wed, 04 Nov 2009 10:53:00 EST

ENGLEWOOD, CO--(Marketwire - November 4, 2009) - Biomedical Technology Solutions Holdings, Inc. ("BMTS" or the "Company"; www.bmtscorp.com) (OTCBB: BMTL) is pleased to announce the introduction of the Demolizer� II System into the Geisinger Health organization for the onsite treatment of biomedical waste.

The Geisinger Health System is one of the nation's leading fully integrated health services organizations. Founded in 1915, Geisinger is a physician-led health care system, dedicated to health care, education, research and service spanning 43 counties in Pennsylvania and serving over 2.6 million people in primarily rural communities.

InFusion SCADA 2.0 Offering From Invensys Delivers New Functionality, Flexibility and Security for Remote Operations

Wed, 04 Nov 2009 10:00:00 EST

Comprehensive Solution Has RTUs for Oil & Gas, Water & Wastewater Applications

MorphoSys to Present at Two Upcoming Investor Conferences

Wed, 04 Nov 2009 08:05:00 EST

MUNICH, GERMANY--(Marketwire - November 4, 2009) -

MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that its management will give company presentations at two upcoming investor conferences.

Deutsche B�rse Group - German Equity Forum
Date: Tuesday, November 10, 2009
Time: 03:00 pm CET (02:00 pm GMT, 09:00 am ET)
Venue: Frankfurt/Main, Germany
Presenter: Dave Lemus, CFO of MorphoSys AG

WestLB Germany Conference
Date: Wednesday, November 18, 2009
Time: 12:30 pm CET (11:30 am GMT, 06:30 am ET)
Venue: Frankfurt/Main, Germany
Presenter: Dr. Simon Moroney, CEO of MorphoSys AG

Advanced Clean Technologies Retains WorldMarketMedia.com to Design and Implement Their Social Media Marketing Campaign

Wed, 04 Nov 2009 08:00:00 EST

HUNTINGTON BEACH, CA--(Marketwire - November 4, 2009) - Advanced Clean Technologies, Inc. (PINKSHEETS: ACTH) announces the retention of World Market Media, Inc. to lead the Company's Social Media Marketing efforts.

Ronald P. Russo, Jr., Founder & Social Equity Officer, states, "We are delighted that the Advanced Clean Technologies management team has engaged World Market Media to design and implement their Social Media Distribution Plan and Platform."

Agrium Reports Third Quarter Results

Wed, 04 Nov 2009 07:00:00 EST

CALGARY, ALBERTA--(Marketwire - Nov. 4, 2009) - ALL AMOUNTS ARE STATED IN U.S.$ Agrium Inc. (TSX:AGU) (NYSE:AGU) announced today net earnings of $26-million ($0.16 diluted earnings per share) for the third quarter of 2009, compared with the net earnings of $367-million in the third quarter of 2008 ($2.31 diluted earnings per share). The 2009 third quarter results included gains of $5-million ($0.02 diluted earnings per share) on derivative financial instruments and a $25-million expense ($0.11 decrease in diluted earnings per share) in stock-based compensation. It also included an inventory write-down of $9-million (a $0.04 decrease in diluted earnings per share) primarily associated with our Wholesale purchase for resale business. Excluding these items, our net earnings would have been $46-million ($0.29 diluted earnings per share) for the third quarter of 2009.

The Clorox Company Joins the Business Coalition for Workplace Fairness

Tue, 03 Nov 2009 17:00:00 EST

Supports Employment Nondiscrimination Act

Yasheng Group Reports 2009 Second Quarter Financial Results

Tue, 03 Nov 2009 14:56:00 EST

REDWOOD CITY, CA--(Marketwire - November 3, 2009) - Yasheng Group (PINKSHEETS: YHGG), a leading agriculture company focused on the China market, today reported financial results for the three months ended June 30, 2009.

For the second quarter ended June 30, 2009, gross profit increased to $20,989,622, compared to $19,791,614 for the second quarter of 2008. Net income was $19,687,110, or $0.13 per share, for the second quarter of 2009, compared with net income of $18,258,441, or $0.12 per share, for the second quarter of 2008.

Alta funcionalidad a su alcance: Las balanzas Serie FZ-i de A&D Weighing

Tue, 03 Nov 2009 13:15:00 EST

SAN JOSE, CA--(Marketwire - November 3, 2009) - A&D Weighing se enorgullece en anunciar la introducci�n de la Serie FZ-i de balanzas de precisi�n, con calibraci�n interna. La FZ-i tiene todas las caracter�sticas de alto rendimiento que los usuarios han llegado a esperar de la Serie FX-i, m�s la adici�n de calibraci�n de un solo paso. Con solo presionar una tecla, usted puede asegurar la precisi�n de su balanza.

Caracter�sticas importantes incluyen:

SNRG Corporation Announces License Agreement

Tue, 03 Nov 2009 12:18:00 EST

HOUSTON, TX--(Marketwire - November 3, 2009) - SNRG Corporation (PINKSHEETS: SNRG) announced this morning that the Company has entered into an exclusive North American technology agreement with Vega Invest AG d/b/a Enviropark Global AG for advanced waste processing and materials recovery technologies.

The agreement grants the Company all North American rights to the Enviropark concept and related technologies. The Enviropark model brings together a matrix of waste streams that create an economically viable combination of revenue from tipping fees and the sale of recycled materials on the upstream side of gasification and revenues from materials and products derived from the syngas and inorganic liquids produced from the gasification of a blended waste feedstock.

NanoMarkets Announces New Upcoming Report on Silver Inks and Pastes for Printed Electronics

Tue, 03 Nov 2009 11:42:00 EST

GLEN ALLEN, VA--(Marketwire - November 3, 2009) - NanoMarkets, a leading industry analyst firm based in Virginia, today announced a new upcoming report that continues the firm's coverage of emerging electronic materials markets. The report, " Silver Inks and Pastes: 2009 to 2016-Nano-151" is scheduled to release the week of November 9th of 2009. Details about the report including a table of contents and excerpt are available at www.nanomarkets.net. Members of the press may request an executive summary of the report.

Itronics Obtains GOLD'n GRO Fertilizer Inventory Funding

Tue, 03 Nov 2009 10:10:00 EST

Strong Growth Being Driven by Environmentally Green Fertilizer Technology

Sigma(R) Life Science Appoints Impress Public Relations as Agency of Record

Tue, 03 Nov 2009 10:00:00 EST

PHOENIX, AZ--(Marketwire - November 3, 2009) - Impress Public Relations, Inc. today announced that it has been appointed as public relations agency of record by Sigma Life Science, part of the Sigma-Aldrich Corporation and a world leader in innovative products and services serving the global Life Science market.

With a global customer base covering pharmaceutical companies, university and government institutions, hospitals and industrial accounts, Sigma Life Science offers an array of biological-based chemicals and reagents used by research scientists in the investigation of new or enhanced methods in therapeutic areas. The company also offers a comprehensive range of media, reagents and serum products for Cell Culture, as well as a wide range of market-leading kits for use in Cell Biology, Proteomics, Genomics and Functional Genomics, and is a leading supplier of custom peptid

Camber Corporation Earns a Spot on 2009 InformationWeek 500 List of Top Technology Innovators Across America

Tue, 03 Nov 2009 09:15:00 EST

HUNTSVILLE, AL--(Marketwire - November 3, 2009) - Camber Corporation is honored to announce its selection for the prestigious 2009 InformationWeek 500 list of top technology innovators. The annual award recognizes the nation's most innovative users of business technology. The InformationWeek 500 rankings are unique, focusing on the power of innovation in information technology, rather than simply identifying the biggest IT spenders.

"We're a service-oriented team. From the help desk and field service engineers, to our integrated process and management teams, we drive our technology strategy to facilitate the patterns and performance of our customers -- not the other way around," said Camber's CIO Wayne Blockel.

Bio-Clean International Enters Into Letter of Intent to Acquire Clean Energy Company

Tue, 03 Nov 2009 08:00:00 EST

HUNTINGTON BEACH, CA--(Marketwire - November 3, 2009) - Bio-Clean International, Inc. (PINKSHEETS: BCLE) announced today that, through its newly established subsidiary, Bio-Clean Energy, Inc., it has entered into a Letter of Intent to acquire all of the capital stock of Nipatech Energy, Inc., a California-based company, which is involved in the development of ethanol production facilities in the Philippines.

James E. Shipley, President of Bio-Clean International, stated, "We are excited about this new opportunity. It takes Bio-Clean into a new realm of eco-friendly business opportunities and we expect it to bring significant revenues to the company. In light of our outreach into this new business segment, our Board of Directors intends to change the name of the company to Global Planet Services, Inc. Effectiveness of the change of name will follow shareholder, governmental and regulatory approval of this action

Advanced Clean Technologies Completes Acquisition of Environmental Remediation Company

Tue, 03 Nov 2009 08:00:00 EST

HUNTINGTON BEACH, CA--(Marketwire - November 3, 2009) - Advanced Clean Technologies, Inc. (PINKSHEETS: ACTH) announced today that it has completed the acquisition of American Petroleum Solutions, Inc., (API), which holds an exclusive license for a patented, oil sludge removal technology. Current ACTH clients already include some of the largest oil and gas companies in the US including ConocoPhillips, ExxonMobil, Avon Petroleum, Valero Petroleum, as well as the US Navy Petroleum Reserve. "This strategic addition to our company, strengthens our offering in the oil and gas industry and accelerates our growth plans," said Russell Kidder, CEO.

Reflect Scientific Consolidates Cryometrix Product Line to Montana Facility

Tue, 03 Nov 2009 06:18:00 EST

OREM, UT--(Marketwire - November 3, 2009) - Reflect Scientific, Inc. (OTCBB: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries announced the integration of its Cryometrix operation into its Bozeman, Montana facility.

It has been a goal of Reflect Scientific to consolidate product lines to gain economic as well as operational efficiencies where possible. Moving the Cryometrix operation from California to the engineering center in Montana reduces costs by an estimated $900,000 a year and creates a single, more productive engineering group for the company.

DSM delivers strong result improvement in Q3

Tue, 03 Nov 2009 02:08:00 EST

HEERLEN, NETHERLANDS--(Marketwire - November 3, 2009) -

* Q3 operating profit from continuing operations EUR 139 million, more than double Q2 2009 (EUR 58 million)

* Strong Life Sciences performance due to robust Nutrition business

* Materials Sciences continued strong recovery

* Cost savings and efficiency improvements on track to achieve EUR 150 - 200 million on yearly basis by 2010

* Cash flow from operating activities again very strong (Q3 EUR 517 million)

Crucell Announces Third Quarter 2009 Results

Tue, 03 Nov 2009 01:57:00 EST

LEIDEN, NETHERLANDS--(Marketwire - November 3, 2009) -

Total revenues and other operating income increased by 15% to EUR 94.3
million.
Operating profit of EUR 15.5 million versus EUR 9.6 million in Q3 2008.
Quarter-end cash and short-term liquidities of EUR 411.9 million.
Undiluted EPS of EUR 0.15 for the quarter.

2009 full year guidance reiterated: total revenues and other operating income expected to grow 20% in constant currencies ; operating profit for 2009 expected to improve significantly compared to 2008; strong cash position.

HydroGenetics, Inc. Announces Update

Mon, 02 Nov 2009 18:00:00 EST

MIAMI, FL--(Marketwire - November 2, 2009) - HydroGenetics, Inc. (PINKSHEETS: HYGN) and its subsidiary Buffalo BioDiesel, Inc., jointly announced today that they agreed to unwind their share exchange agreement entered into in December 2008. Charles Hansen, III, the current CEO of HydroGenetics, Inc., explained that, "My vision for the future of our company is to focus on hydrogen on demand cell technology for the internal combustion engine and working with inventors of breakthrough alternative energy technology. In order to accomplish this, we will divest our holdings of companies that are in other business lines and continue our development of hydrogen cell technology. Sumit [Majumdar, CEO of Buffalo BioDiesel, Inc.] agreed that an unwind at this time would be best for both companies." Sumit Majumdar stated that, "Buffalo BioDiesel, Inc. believed in 2008 that our roll-up into a broadly focused green energy congl

Lapolla Reports Record Third Quarter 2009 Results

Mon, 02 Nov 2009 17:54:00 EST

Delivers Operating Profit and Revenue Growth

Olin to Present at Oppenheimer and Citigroup Global Markets Conferences

Mon, 02 Nov 2009 11:25:00 EST

CLAYTON, MO--(Marketwire - November 2, 2009) - Olin Corporation's (NYSE: OLN) senior management will make presentations at the Oppenheimer Fourth Annual Industrials Conference in New York City on November 17, 2009 at 10:15 AM Eastern Time; and at the Citigroup Global Markets Basic Materials Conference in New York City on December 1, 2009 at 2:00 PM Eastern Time. Olin's management will be available for one-on-one sessions during each of the conferences.

Clorox Delivers 23 Percent Earnings Growth in Q1, Driven by Robust Gross Margin Expansion

Mon, 02 Nov 2009 08:30:00 EST

OAKLAND, CA--(Marketwire - November 2, 2009) - The Clorox Company (NYSE: CLX) today reported strong earnings growth, driven by robust gross margin expansion and modest volume growth, for its first quarter, which ended Sept. 30.

"We had a great first quarter, especially given the continued challenging economic environment and the impact of weaker foreign currencies," said Chairman and CEO Don Knauss. "Most of our businesses performed well, and we exceeded our earnings expectations due to strong sales of disinfecting products related to the H1N1 flu pandemic. We also delivered our third consecutive quarter of significant gross margin improvement."

Clorox Announces Plans to Begin Transitioning U.S. Operations to High-Strength Bleach

Mon, 02 Nov 2009 08:29:00 EST

OAKLAND, CA--(Marketwire - November 2, 2009) - The Clorox Company (NYSE: CLX) today announced that it plans to begin modifying manufacturing processes in its U.S. bleach operations. The initiative calls for Clorox to begin transitioning from chlorine to high-strength bleach as a raw material for making its namesake bleach.

"This decision was driven by our commitment to strengthen our operations and add another layer of security," said Chairman and CEO Don Knauss.

Locus Offers Free GHG Calculator for CA Mandatory Reporting

Mon, 02 Nov 2009 07:00:00 EST

Industry Leader Takes Action to Help With GHG Reporting

Tesco Teams Up With BatteryBack

Mon, 02 Nov 2009 05:39:00 EST

LEEDS, UNITED KINGDOM--(Marketwire - Nov. 2, 2009) - Tesco is the latest major retailer to join the BatteryBack producer compliance scheme, which is on target to be the largest of the recently approved schemes. With only one week to go before the deadline for producers, retailers appreciate the strengths of the BatteryBack scheme.

BatteryBack has been able to guarantee low collection fees for the next three years by utilising the existing infrastructure managed by Veolia Environmental Services and WasteCare. BatteryBack has also announced a recent partnership with PHS which will expand the potential collection network to over 200,000 sites throughout Britain.

Flutiform EU Clinical Trial Successfully Completed

Mon, 02 Nov 2009 05:24:00 EST

LONDON--(Marketwire - November 2, 2009) -


FOR IMMEDIATE RELEASE


SkyePharma Announces Successful Completion of

FlutiformTM EU Clinical Trial Programme


LONDON, UK, 2 November, 2009 - SkyePharma PLC (LSE: SKP) today
announces that its development and marketing partner Mundipharma
International Corporation Limited ("Mundipharma") has successfully
completed the final Phase III clinical study for the European
development programme for FlutiformTM, with the higher dose strength
study (FLT 3503) meeting its primary endpoints. This will enable the
regulatory filing with the European authorities to take place in Q1
2010 as planned.


Study FLT-3503 included 529 patients, who met the requirements for the"per
protocol" analysis, and were suffering from severe, persistent and
reversible asthma. They were treated in an eight week double-blind,
double dummy, randomised multiple centre four arm parallel group study
to assess t

Lapolla and ABC's "Extreme Makeover: Home Edition" Lewisport, KY Project

Fri, 30 Oct 2009 18:37:00 EDT

Mattingly Family Home Episode Airs Sunday, November 1, 2009 at 8/7c on ABC

ABLYNX ANNOUNCES WARRANT EXERCISE

Fri, 30 Oct 2009 13:10:00 EDT

GHENT, BELGIUM--(Marketwire - October 30, 2009) - Ablynx [Euronext Brussels: ABLX] today announced that an additional 4,407 common shares have been issued by the Company in exchange for EUR 6,732.60 as the result of the exercise of warrants by some employees and consultants of the Company.

As a result of this transaction, Ablynx now has 36,889,789 shares outstanding.

-ends-

About Ablynx [Euronext Brussels: ABLX] - http://www.ablynx.com Founded in 2001 in Ghent, Belgium, Ablynx is a biopharmaceutical company focused on the discovery and development of Nanobodies�, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious and life-threatening human diseases. The Company currently has over 220 employees. Ablynx completed a successful IPO on Euronext Brussels [ABLX] on 7 November 2007.